Chromosome 17p deletion
MONDO:0022754A cytogenetic abnormality that refers to the allelic loss of all or part of the short arm of chromosome 17.
Also known as: chromosome 17p deletion, partial deletion of chromosome 17p, partial deletion of the short arm of chromosome 17, partial monosomy of chromosome 17p, partial monosomy of the short arm of chromosome 17, partial monosomy of the short arm of chromosome type 17, 17p deletion, 17p monosomy
9 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New targeted drug shows promise for Hard-to-Treat leukemia
Disease control CompletedThis study tested a drug called acalabrutinib in 48 adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who had a specific high-risk genetic change (deletion 17p). Some participants had already tried other treatments, while others were newly diagnos…
Phase: PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New combo shows promise for Tough-to-Treat myeloma
Disease control CompletedThis study tested a combination of pomalidomide and dexamethasone in 63 patients with multiple myeloma that had returned or stopped responding to treatment, and who had specific high-risk genetic changes. The goal was to see how well the drugs controlled the disease and what side…
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New cocktail aims to tackle tough leukemia
Disease control CompletedThis phase II study tested a combination of three drugs—ibrutinib, fludarabine, and pembrolizumab—in 15 people with high-risk or relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal was to see if the combo could produce a complete r…
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC